Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia.

Autor: Ren, Jun1 (AUTHOR), Huang, Junpeng1 (AUTHOR), Yang, Zailin2 (AUTHOR), Sun, Minghui1 (AUTHOR), Yang, Jing1 (AUTHOR), Lin, Can1 (AUTHOR), Jin, Fangfang1 (AUTHOR), Liu, Yongcan1 (AUTHOR), Tang, Lisha1 (AUTHOR), Hu, Jiayuan1 (AUTHOR), Wei, Xingyu1 (AUTHOR), Chen, Xinyi1 (AUTHOR), Yuan, Zihao1 (AUTHOR), Yang, Zesong3 (AUTHOR), Chen, Yanmeng1 (AUTHOR) yanmengchen@cqmu.edu.cn, Zhang, Ling1 (AUTHOR) lingzhang@cqmu.edu.cn
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 6/22/2024, Vol. 43 Issue 1, p1-20. 20p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje